4-methylumbelliferyl beta-D-glucoside
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- 4-methylumbelliferyl beta-D-glucoside
- DrugBank Accession Number
- DB13177
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 338.3093
Monoisotopic: 338.100167552 - Chemical Formula
- C16H18O8
- Synonyms
- 4-methylumbelliferyl beta-D-glucoside
- 4-Methylumbelliferyl glucoside
- 4-methylumbelliferyl β-D-glucoside
- 4-Methylumbelliferyl-beta-D-glucoside
- 4-Methylumbelliferyl-beta-glucoside
- 7-(beta-D-Glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with 4-methylumbelliferyl beta-D-glucoside. Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with 4-methylumbelliferyl beta-D-glucoside. Dexmethylphenidate The serum concentration of the active metabolites of 4-methylumbelliferyl beta-D-glucoside can be increased when 4-methylumbelliferyl beta-D-glucoside is used in combination with Dexmethylphenidate. Diazoxide The serum concentration of 4-methylumbelliferyl beta-D-glucoside can be increased when it is combined with Diazoxide. Doxycycline The therapeutic efficacy of 4-methylumbelliferyl beta-D-glucoside can be increased when used in combination with Doxycycline. - Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as coumarin glycosides. These are aromatic compounds containing a carbohydrate moiety glycosidically bound to a coumarin moiety.
- Kingdom
- Organic compounds
- Super Class
- Phenylpropanoids and polyketides
- Class
- Coumarins and derivatives
- Sub Class
- Coumarin glycosides
- Direct Parent
- Coumarin glycosides
- Alternative Parents
- Phenolic glycosides / Hexoses / O-glycosyl compounds / 1-benzopyrans / Pyranones and derivatives / Benzenoids / Oxanes / Heteroaromatic compounds / Secondary alcohols / Lactones show 6 more
- Substituents
- 1-benzopyran / Acetal / Alcohol / Aromatic heteropolycyclic compound / Benzenoid / Benzopyran / Coumarin o-glycoside / Coumarin-7-o-glycoside / Glycosyl compound / Heteroaromatic compound show 17 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- 18997-57-4
- InChI Key
- YUDPTGPSBJVHCN-YMILTQATSA-N
- InChI
- InChI=1S/C16H18O8/c1-7-4-12(18)23-10-5-8(2-3-9(7)10)22-16-15(21)14(20)13(19)11(6-17)24-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13-,14+,15-,16-/m1/s1
- IUPAC Name
- 4-methyl-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one
- SMILES
- CC1=CC(=O)OC2=CC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=CC=C12
References
- General References
- Not Available
- External Links
- ChemSpider
- 2015550
- BindingDB
- 18352
- ChEBI
- 91117
- ChEMBL
- CHEMBL1441570
- ZINC
- ZINC000004073899
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 5.11 mg/mL ALOGPS logP -0.34 ALOGPS logP -0.49 Chemaxon logS -1.8 ALOGPS pKa (Strongest Acidic) 12.2 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 125.68 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 79.96 m3·mol-1 Chemaxon Polarizability 32.79 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-004r-0904000000-633a124b1c722ee9f38b Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-002r-0917000000-3d44a08353928870a083 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-0921000000-bb5549e7427eba5124c8 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-056r-1933000000-e9a88f45a64f69fef3e0 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-1940000000-08a73b638934e842392c Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0159-6900000000-e7a821178dbcc7deedf0 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 174.00452 predictedDeepCCS 1.0 (2019) [M+H]+ 176.40009 predictedDeepCCS 1.0 (2019) [M+Na]+ 182.3126 predictedDeepCCS 1.0 (2019)
Drug created at May 30, 2017 17:03 / Updated at June 12, 2020 16:53